Mitochondrial Dysfunction in Neurodegenerative Diseases
Cells · 13.02.2025 · 14 (4) · 276
DOI: 10.3390/cells14040276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.02.2025. Verfasst von Han-Mo Yang. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Mitochondria. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, “National Research Foundation of Korea (NRF)”, Korean government.
Abstract (Originalsprache)
Mitochondrial dysfunction represents a pivotal characteristic of numerous neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. These conditions, distinguished by unique clinical and pathological features, exhibit shared pathways leading to neuronal damage, all of which are closely associated with mitochondrial dysfunction. The high metabolic requirements of neurons make even minor mitochondrial deficiencies highly impactful, driving oxidative stress, energy deficits, and aberrant protein processing. Growing evidence from genetic, biochemical, and cellular investigations associates impaired electron transport chain activity and disrupted quality-control mechanisms, such as mitophagy, with the initial phases of disease progression. Furthermore, the overproduction of reactive oxygen species and persistent neuroinflammation can establish feedforward cycles that exacerbate neuronal deterioration. Recent clinical research has increasingly focused on interventions aimed at enhancing mitochondrial resilience—through antioxidants, small molecules that modulate the balance of mitochondrial fusion and fission, or gene-based therapeutic strategies. Concurrently, initiatives to identify dependable mitochondrial biomarkers seek to detect pathological changes prior to the manifestation of overt symptoms. By integrating the current body of knowledge, this review emphasizes the critical role of preserving mitochondrial homeostasis as a viable therapeutic approach. It also addresses the complexities of translating these findings into clinical practice and underscores the potential of innovative strategies designed to delay or potentially halt neurodegenerative processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
ORCID-Profile: Han-Mo Yang
Förderung
- National Research Foundation of Korea
- “National Research Foundation of Korea (NRF)”
- Korean government
Zitieren
APA
Yang, H. M. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells, 14(4), 276. https://doi.org/10.3390/cells14040276
Vancouver
Yang HM. Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells. 2025;14(4):276. doi:10.3390/cells14040276
BibTeX
@article{Yang2025,
author = {Yang, Han-Mo},
title = {Mitochondrial Dysfunction in Neurodegenerative Diseases},
journal = {Cells},
year = {2025},
volume = {14},
number = {4},
pages = {276},
doi = {10.3390/cells14040276}
}
EUVIMED